Yakult

News Releases

Anticancer drug “Elplat®” Approval for the Additional Indication of Unresectable Advanced or Recurrent Gastric Cancer

Mar 2015

Back

Fiscal year

More
トップへ戻る

Our website uses cookies to provide users with a better service. Please click on “Accept” if you agree to our use of cookies. Click on “See details” for information on cookies and their setting.

Accept
See details